ArticleMolecular cancer therapeutics2011

The novel Bcl-2 inhibitor ABT-737 is more effective in hypoxia and is able to reverse hypoxia-induced drug resistance in neuroblastoma cells.

Tetyana Klymenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.